Concepedia

Allan Hallett

AH

20

Publications

708

Citations

17

H-Index

1975

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

Western Infirmary

Novartis (Japan)

Novartis Institutes for BioMedical Research

Allan Hallett is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1975–2012

20

Publications

20

Bradyzide, a potent non‐peptide B<sub>2</sub> bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia

Gillian M. Burgess, Martin Perkins, H P Rang et al. · British Journal of Pharmacology · 2000 · 104 citations · Full text

The structure of a synthetic pepsin inhibitor complexed with endothiapepsin

Jonathan M. Cooper, S. Foundling, Andrew M. Hemmings et al. · European Journal of Biochemistry · 1987 · 67 citations · Full text

, , +17

Thioamide Synthesis:  Thioacyl-<i>N</i>-phthalimides as Thioacylating Agents

Christopher T. Brain, Allan Hallett, Soo Y. Ko · The Journal of Organic Chemistry · 1997 · 60 citations

, , +8

Identification and Biological Characterization of 6-Aryl-7-isopropylquinazolinones as Novel TRPV1 Antagonists that Are Effective in Models of Chronic Pain

Andrew J. Culshaw, Stuart Bevan, Martin Lau Christiansen et al. · Journal of Medicinal Chemistry · 2005 · 59 citations · Full text

, , +20

A Study of the Renin Inhibitor H142 in Man

David J. Webb, Per Manhem, Stephen G. Ball et al. · Journal of Hypertension · 1985 · 55 citations

Rows per page

1–5 of 20